Use: Labeled indications
- Uses temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies temporarily relieves sinus congestion and pressure
Full indications and usage US FDA label
Uses temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies temporarily relieves sinus congestion and pressure
Dosing: Adult
Dosage and administration (US label) US FDA label
Directions find right dose on chart below mL = milliliter repeat dose every 4 hours do not use more than 6 times in 24 hours Age (yr) Dose (mL) under 4 years do not use 4 to 5 years 5 mL 6 to 11 years 10 mL Attention: use only enclosed dosing cup specifically designed for use with this product. Do not use any other dosing device.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Syrup: 1 mg/1 mL, 5 mg/5 mL, 12.5 mg/5 mL
- ) solution for i.v. injection: 50 mcg/mL (500 mcg/10 mL
- Ophthalmic solution: 25 mg/mL
- Sterile ophthalmic solution: 25 mg/mL
Registered products in the Philippines
8 products registered with the Food and Drug Administration (FDA) Philippines list Phenylephrine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products8
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
COLDIMARPhenylephrine Hydrochloride | 5mg/5mL Syrup (Cherry Flavor)Boston Round Amber Bottle x 60mL with Aluminum Cap Box of 1's | OTC | San Marino Laboratories CorporationPhilippines | Trader: Johntann Internationale Pharmaceutical Corp. | DRP-8163 | Apr 4, 2029 | |
FenlomaxPhenylephrine hydrochloride | 25mg/mL (2.5% w/v) Ophthalmic Solution (Eye Drops)White LDPE Bottle with Screw Cap x 5mL (Box of 1’s) | Rx | Makers Laboratories LtdIndia | Blue Global (FZE) | DRP-18135 | May 13, 2031 | |
LedeconPhenylephrine Hydrochloride | Syrup 12.5mg/5mLBoston Round Amber Bottle x 60mL Box of 1's | OTC | LEJAL LABORATORIES INC.Philippines | — | DR-XY32494 | Oct 25, 2028 | |
MydfrinPhenylephrine Hydrochloride | 25 mg/mL (2.5% w/v) Sterile Ophthalmic SolutionPlastic Droptainer x 5 mL (Box of 1's) | Rx | Alcon Research LLCUnited States of America | Importer: Alcon Laboratories (Phils.), Inc. | DR-XY16997 | Oct 29, 2031 | |
NaldecPhenylephrine Hydrochloride | 12.5 mg / 5 mL SyrupBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | OTC | La Croesus Pharma, Inc.Philippines | Trader: IAE Pharmaceuticals Corporation | DR-XY43311 | Mar 17, 2029 | |
NasadrinPhenylephrine Hydrochloride (Melon Flavor) | 12.5 mg/5 mL SyrupAmber Glass Bottle x 60 mL (Box of 1's) | OTC | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-13093 | Sep 10, 2029 | |
PhenylalphaPhenylephrine (as hydrochloride) | 50 mcg/mL (500 mcg/10 mL) Solution for I.V. Injection10 mL (Net Content) Polypropylene Ampoule (Box of 10's) | Rx | Laboratoire AguettantFrance | The Cathay Drug Co., Inc. | DR-XY48056 | May 27, 2027 | |
Robitussin Sinus ReliefPhenylephrine Hydrochloride | 1 mg/1 mL SyrupAmber Bottle Sealed with Child-resistant Cap x 200 mL with Medicine Cup (Box of 1's) | OTC | Interphil Laboratories, Inc.Philippines | — | DR-XY37467 (For Export Only) | Feb 11, 2030 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
Warnings Do not use in a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child's prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product.
Ask a doctor before use if the child has heart disease high blood pressure thyroid disease diabetes a sodium-restricted diet When using this product do not exceed recommended dose Stop use and ask a doctor if nervousness, dizziness, or sleeplessness occur symptoms do not improve within 7 days or occur with a fever Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
(1-800-222-1222)
Formulary and pricing (Philippines)
Formulary and coverage
| Philippine National Formulary | Listed as Phenylephrine (as hydrochloride) |
| PNF listing | Eye Drops Solution: 2.5%, 5 mL bottle |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Childrens Sudafed PE NASAL DECONGESTANT · Kenvue Brands LLC [US FDA-approved label, version 11, November 4, 2024]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4dfd46e4-b9f9-464d-aa47-e8fa9e526a5d
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .